Aelis Farma (FRA:69O) Shares Outstanding (EOP): 13.63 Mil (As of Dec. 2025)


FRA:69O Aelis Farma SA FRA:69O
32 GF Score
Price €1.04
GF Value €0.95
! 4 Warning Signs
View Full Analysis

What is Aelis Farma Shares Outstanding (EOP)?

Aelis Farma FRA:69O +1.17% 32 Shares Outstanding (EOP) is 13.63 Mil as of Dec. 2025. GuruFocus rates FRA:69O with a GF Score™ of 32/100 and a GF Value™ of €0.95. The stock has 4 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Aelis Farma's shares outstanding for the quarter that ended in Dec. 2025 was 13.63 Mil.

Aelis Farma's quarterly shares outstanding increased from Jun. 2025 (13.62 Mil) to Dec. 2025 (13.63 Mil). It means Aelis Farma issued new shares from Jun. 2025 to Dec. 2025 .

Aelis Farma's annual shares outstanding increased from Dec. 2024 (13.62 Mil) to Dec. 2025 (13.63 Mil). It means Aelis Farma issued new shares from Dec. 2024 to Dec. 2025 .


Aelis Farma  (FRA:69O) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Aelis Farma Shares Outstanding (EOP) Related Terms


Aelis Farma Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Aelis Farma's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aelis Farma Shares Outstanding (EOP) Chart

Aelis Farma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only 9.59 12.50 13.18 13.62 13.63

Aelis Farma Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.18 13.17 13.62 13.62 13.63

FRA:69O vs VRTX, REGN, ALNY: Shares Outstanding (EOP) Comparison

For the Biotechnology subindustry, Aelis Farma's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aelis Farma Shares Outstanding (EOP) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aelis Farma's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Aelis Farma's Shares Outstanding (EOP) falls into.


FRA:69O
32GF Score
Aelis Farma SA FRA:69O
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aelis Farma Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 13.63 Mil mean?
Aelis Farma (FRA:69O) has a Shares Outstanding (EOP) of 13.63 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on Aelis Farma and its competitors.
Is Aelis Farma's Shares Outstanding (EOP) too high?
Aelis Farma's current Shares Outstanding (EOP) is 13.63 Mil. Overall, Aelis Farma has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Aelis Farma's Shares Outstanding (EOP) compare to VRTX and REGN?
Aelis Farma's Shares Outstanding (EOP) of 13.63 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Biotechnology company?
A good Shares Outstanding (EOP) depends on the Biotechnology industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Aelis Farma and its competitors. Aelis Farma's current Shares Outstanding (EOP) is 13.63 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aelis Farma stock overvalued right now?
Aelis Farma (FRA:69O) has a current Shares Outstanding (EOP) of 13.63 Mil. The stock's GF Value™ is €0.95, compared to a current price of €1.04 — trading 9.1% above its estimated fair value. The current Shares Outstanding (EOP) is 13.63 Mil. Aelis Farma's overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Aelis Farma (FRA:69O), the current Shares Outstanding (EOP) is 13.63 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aelis Farma (FRA:69O) Overvalued in 2026?

Based on GuruFocus' analysis, Aelis Farma stock appears to be overvalued. The current stock price of €1.04 is trading 9.1% above its estimated GF Value™ of €0.95.

Key valuation signals for FRA:69O:

  • Shares Outstanding (EOP): 13.63 Mil
  • GF Value™: €0.95 vs. price of €1.04 (9.1% above fair value)
  • GF Score™: 32/100 with 4 warning signs

No single metric tells the full story. See the FRA:69O stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aelis Farma Business Description

Other Exchanges AELIS:France
Address 2 rue Robert Escarpit, IECB, Pessac, Bordeaux, FRA, 33607
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases. The Company operates in only one business segment: the research and development of pharmaceutical products.
32GF Score

Get the complete analysis for FRA:69O

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.04
Price
€0.95
GF Value